Insider Shareholders with Direct Ownership of Kintara Therapeutics, Inc. (KTRA)
This section provides a comprehensive overview of the insiders with direct ownership of Kintara Therapeutics, Inc. (KTRA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kintara Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
James A. Bianco
Chief Executive Officer |
2,323,307 | 0 | 2,323,307 $511,127 | 1 |
Oct 18, 2024
Added 50.0%
|
|
Anthony Scott Praill
Chief Financial Officer |
269,799 | 0 | 277,273 $61,000 | 6 |
Aug 01, 2022
Added 46.41%
|
|
Robert E. Hoffman
President, CEO and Interim CFO |
514,945 | 0 | 68,902 $15,158 | 3 |
Jun 01, 2023
Added 46.46%
|
|
Saiid Zarrabian
Head of Strategic Partnerships |
50,000 | 0 | 55,500 $12,210 | 2 |
Dec 07, 2021
Added 40.71%
|
|
Dennis M Brown
Chief Scientific Officer |
241,257 | 0 | 5,302 $1,166 | 6 |
Jan 05, 2023
Added 6.41%
|
|
Laura L. Johnson
Director |
3,000 | 0 | 3,000 $660 | 1 |
Nov 22, 2021
Added 50.0%
|
|
Robert Joseph Toth Jr
Director |
352 | 0 | 1,566 $344 | 4 |
Apr 29, 2021
Added 17.19%
|